2018 Radford Long-Term Incentive Practices Report for Life Sciences Companies

A deep-dive into the current state of long-term incentive plan design and strategy


Overview

Developing a competitive long-term incentive program with the capacity to evolve and scale with your business is no easy task. This is particularly true in the life sciences sector, where market volatility and the ups and downs of drug development can swiftly change the fortunes of any organization in minutes. To support life sciences companies in dealing with these challenges, our new report provides an unparalleled data-driven view of the current equity compensation landscape across all employee levels and company types within the sector.

The cost to purchase this ground-breaking study, including comprehensive data from 169 pre-commercial and 109 commercial companies, is $2,500.

    Buy Now           Learn More  

What's covered in this study?

The 2018 Radford Long-Term Practices Report for Life Sciences Companies provides critical insights into topics like equity eligibility and participation rates, equity vehicle prevalence and mix by employee level, vesting schedules, aggregate equity spend and more. The table of contents includes:

Section 1: Introduction

Section 2: Summary of Key Findings

Section 3: Study Overview

  • Participant Financials

Section 4: Equity Practices

  • Ongoing Equity Awards 
  • Vehicile Prevalence/Mix
  • New-Hire Awards
  • LTI Award Differentiation
  • LTI Premiums for Scientists vs Non- Scientists
  • Global LTI Discounts
  • Stock Option Practices
  • Aggregate Equity Spend

Section 5: Tips on Equity Strategy

Section 6: Overview of Equity


Images shown are for illustrative purposes only and may not reflect actual data.

Which companies are included in the study?

This report includes data from 169 pre-commercial and 109 commercial life sciences companies including:

Pre-Commercial Companies

  • Acceleron Pharma
  • Acelrx Pharmaceuticals
  • Achaogen
  • Achillion Pharmaceuticals
  • Aclaris Therapeutics
  • Acucela
  • Adamas Pharmaceuticals
  • Adaptimmune
  • Aduro Biotech
  • Advaxis
  • Adverum Biotechnologies
  • Aeglea Biotherapeutics
  • Aerie Pharmaceuticals
  • Aevi Genomic Medicine
  • Agenus
  • Agios Pharmaceuticals
  • Aimmune Therapeutics
  • Akebia Therapeutics
  • Alder Biopharmaceuticals
  • Alnylam Pharmaceuticals
  • Altimmune
  • Anaptysbio
  • Applied Genetic Technologies
  • Aptevo Therapeutics
  • Aquinox Pharmaceuticals
  • Aradigm
  • Arbutus Biopharma
  • Ardelyx
  • Arena Pharmaceuticals
  • Argos Therapeutics
  • Array Biopharma
  • Asterias Biotherapeutics
  • Atara Biotherapeutics
  • Athersys
  • Atyr Pharma
  • Audentes Therapeutics
  • Aveo Pharmaceuticals
  • Avexis
  • Avid Bioservicess
  • Axovant Sciences
  • Beigene Usa
  • Biocryst Pharmaceuticals
  • Bluebird Bio
  • Blueprint Medicines
  • Caladrius Biosciences
  • Calithera Biosciences
  • Cara Therapeutics
  • Cascadian Therapeutics
  • Catabasis Pharmaceuticals
  • Catalyst Biosciences
  • Celldex Therapeutics
  • Cellectar Biosciences
  • Cempra Pharmaceuticals
  • Cerecor
  • Chemocentryx
  • Chiasma
  • Chimerix
  • Cidara Therapeutics
  • Clearside Biomedical
  • Coherus Biosciences
  • Compugen Ltd
  • Concert Pharmaceuticals
  • Corbus Pharmaceuticals
  • Corvus Pharmaceuticals
  • Crispr Therapeutics
  • Curis
  • Cytokinetics
  • Cytomx Therapeutics
  • Cytrx
  • Dermira
  • Dicerna
  • Durect
  • Dynavax Technologies
  • Editas Medicine
  • Eiger Biopharmaceuticals
  • Enanta Pharmaceuticals
  • Endocyte
  • Epizyme
  • Esperion Therapeutics
  • Fibrocell Science
  • Fibrogen
  • Five Prime Therapeutics
  • Genocea Biosciences
  • Geron
  • Global Blood Therapeutics
  • Glycomimetics
  • Greenwich Biosciences
  • Idera Pharmaceuticals
  • Ignyta
  • Immune Design
  • Immunogen
  • Infinity Pharmaceuticals
  • Innocoll
  • Inotek Pharmaceuticals
  • Inovio Pharmaceuticals
  • Insmed
  • Intracellular Therapies
  • Invivo Therapeutics
  • Iovance Biotechnologies
  • Jounce Therapeutics
  • Juno Therapeutics
  • Karyopharm Therapeutics
  • Kempharm
  • La Jolla Pharmaceutical
  • Leap Therapeutics
  • Ligand Pharmaceuticals
  • Lipocine
  • Loxo Oncology
  • Macrogenics
  • Mateon Therapeutics
  • Merrimack Pharmaceuticals
  • Miragen Therapeutics
  • Mirati Therapeutics
  • Molecular Templates
  • Myokardia
  • Myovant Sciences
  • Nektar Therapeutics
  • Novavax
  • Ocular Therapeutix
  • Oncomed Pharmaceuticals
  • Onconova Therapeutics
  • Oncosec Medical
  • Ophthotech
  • Organovo
  • Paratek Pharmaceuticals
  • Pearl Therapeutics
  • Plexxikon
  • Portola Pharmaceuticals
  • Proqr Therapeutics N.V.
  • Proteon Therapeutics
  • Proteostasis Therapeutics
  • Prothena Corporation
  • Radius
  • Regenxbio
  • Regulus Therapeutics
  • Revance Therapeutics
  • Rigel Pharmaceuticals Inc
  • Rxi Pharmaceuticals
  • Sage Therapeutics
  • Sanbio
  • Sangamo Biosciences
  • Selecta Biosciences
  • Seres Therapeutics
  • Sienna Biopharmaceuticals
  • Sierra Oncology
  • Spark Therapeutics
  • Strongbridge Biopharma
  • Sunesis Pharmaceuticals
  • Syndax Pharmaceuticals
  • Syros Pharmaceuticals
  • Tanvex Biopharma Usa
  • Tenax Therapeutics
  • Tetraphase Pharmaceuticals
  • Therapeuticsmd
  • Trevena
  • Ultragenyx Pharmaceutical
  • Uniqure
  • Verastem
  • Versartis
  • Vitae Pharmaceuticals
  • Voyager Therapeutics
  • Wave Life Sciences
  • Xencor
  • Xenon Pharmaceuticals
  • Zafgen
  • Ziopharm Oncology
  • Zogenix
  • Zosano Pharma
  • Zs Pharma

Commercial Companies

  • Abbvie
  • Acadia Pharmaceuticals
  • Acorda Therapeutics
  • Actelion Pharmaceuticals
  • Aegerion Pharmaceuticals
  • Alexion Pharmaceuticals
  • Alk Abello A/S
  • Alkermes
  • Amag Pharmaceuticals
  • Amgen
  • Amicus Therapeutics
  • Antares Pharma
  • Bayer Ag Emea
  • Biogen
  • Biomarin Pharmaceutical
  • Bristol-Myers Squibb Company
  • Btg
  • Celgene
  • Cerus
  • Clovis Oncology
  • Codexis
  • Collegium Pharmaceutical
  • Concordia International
  • Corcept Therapeutics
  • Cti Biopharma
  • Cumberland Pharmaceuticals
  • Daiichi Sankyo
  • Depomed
  • Egalet
  • Eisai
  • Emergent Biosolutions
  • Exelixis
  • F. Hoffmann-La Roche
  • Flexion Therapeutics
  • Galena Biopharma
  • Genmab
  • Gilead Sciences
  • Glaxosmithkline
  • Grifols
  • Halozyme Therapeutics
  • Heron Therapeutics
  • Horizon Pharma
  • Impax Laboratories
  • Incyte
  • Indivior
  • Insys Therapeutics
  • Intercept Pharmaceuticals
  • Ionis Pharmaceuticals
  • Ipsen Pharma
  • Ipsen Us
  • Ironwood Pharmaceuticals
  • Jazz Pharmaceuticals
  • Johnson & Johnson
  • Juniper Pharmaceuticals
  • Keryx Biopharmaceuticals
  • Lexicon Pharmaceuticals
  • Lifecore Biomedical
  • Lundbeck
  • Mallinckrodtmannkind
  • Merck Co
  • Merck Kgaa
  • Momenta Pharmaceuticals
  • Nanostring Technologies
  • Neurocrine Biosciences
  • Novabay Pharmaceuticals
  • Novartis Pharmaceuticals
  • Novo Nordisk Inc
  • Omeros
  • Optinose
  • Orexigen Therapeutics
  • Otonomy
  • Ovascience
  • Pacific Biosciences
  • Pacira Pharmaceuticals
  • Pdl Biopharma
  • Pernix Therapeutics
  • Pfenex
  • Progenics Pharmaceutical
  • Prometic Life Sciences
  • Ptc Therapeutics
  • Raptor Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Relypsa
  • Repligen
  • Retrophin
  • Sanofi Us
  • Sarepta Therapeutics
  • Sciclone Pharmaceuticals
  • Seattle Genetics
  • Senomyx
  • Shire
  • Sobi
  • Sucampo Pharmaceuticals
  • Supernus Pharmaceuticals
  • Takeda Pharmaceuticals
  • Tesaro
  • Teva Pharmaceuticals Usa
  • The Medicines Company
  • Theravance Biopharma Us
  • Titan Pharmaceuticals
  • United Therapeutics
  • Valeant
  • Vanda Pharmaceuticals
  • Vernalis (R&D) Ltd
  • Vertex Pharmaceuticals
  • Vivus

Report Pricing

The 2018 Radford Long-Term Incentive Practices Report for Life Sciences Companies can be purchased via credit card for $2,500